looking good isnt it!
Global nanotechnology company pSivida Limited is pleased to announce that it has received excellent results from the proof of concept study being performed with Epitan Limited
The results indicate that :
pSivida’s porous BioSilicon technology releases MELANOTAN over a sustained period via a single injection
sustained levels of MELANOTAN in the blood for all four formulations
the in-vitro experiments closely mimic the in-vivo responses
The next stage of development will progress to a commercially viable version of this formulation.
PSD
psivida limited
